Acucela

Acucela

  • About Us
  • Therapeutic Approach
  • Pipeline
  • News
  • Careers
  •  
  • Press Releases
  • News
  • Press Coverage
  • Publications
  • Dr. Ryo's Blog

Download Fact Sheet

 

 

Media Inquiries
Please contact:

 

Francesca Nolan

Director, Corporate Communications

> email

206.805.8308

 

 

News

 

2010

Nov

Oct

Sept

Aug

July

June

May

 

11/16/10 Otsuka to announce that they have filed for regulatory approval in Japan for
              rebamipide ophthalmic suspension for dry eye

 

We are pleased to announce Otsuka Pharmaceutical’s release of news on November 9, 2010 that they have filed regulatory approval in Japan for rebamipide ophthalmic suspension for dry eye. Acucela and Otsuka are co-developing rebamipide for the treatment of dry eye in the United States.

 


 

 

 

 

 

 

 

 

 

 

 

 


 

© 2010 Acucela Inc.Japanese Site 日本語

  • Contact Us
  • Sitemap
  • Search
  • Privacy
  • Terms of Use